Background: Point of care (POC) CD4 cell count can reduce the time to eligibility assessment for antiretroviral treatment and improve linkage to care. In a village household setting in Botswana, we evaluated the performance of field POC CD4 testing versus conventional laboratory-based flow cytometry.
Methods: Capillary blood was collected by finger-prick into EDTA microtubes. Venous blood was collected by venipuncture. Both blood collection procedures were performed in households during annual surveys in the village of Mochudi, Botswana. The Alere PIMA® system was used for POC CD4 testing while laboratory testing was performed using BD FacsCalibur. The Bland-Altman method was used to estimate the mean bias and 95% confidence limits of agreement (LOA). Sensitivity and specificity were calculated for a threshold of 500 cells/uL CD4 cell count.
Results: A total of 155 adults were enrolled with CD4 results for both field POC and lab-based testing. The median age was 32 years old and 63% were females. The median CD4 was 827 (IQR 668, 1058) cells/uL. We observed a mean bias between CD4 measurements by POC and FacsCalibur of -14.1 cells/uL [(95% LOA -327.4 – 299.2), paired t-test p = 0.2740] (Figure 1). Using a threshold of 500 CD4 cells/uL, POC CD4 testing using EDTA capillary sampling into microtube had a sensitivity of 73.3 (95% CI 44.9 – 92.3) cells/uL and specificity of 93.6 (88.1 – 97.0) cells/uL.
Conclusions: The Alere PIMA® POC CD4 testing with EDTA capillary sampling into microtube had one of the lowest non-significant negative mean bias relative to FACScalibur CD4 testing, compared previous findings using finger prick sampling alone. There were few measurements below CD4 threshold of 350 cells/uL and sensitivity was low at threshold of 500 cells/uL, but with good specificity. Coupling HIV testing with POC CD4 in a household setting has potential to close gaps in linkage to HIV care in communities.
Figure 1: Bland-Altman plot for comparison of Alere PIMA® CD4 using microtube and FACScalibur